PIPELINE
drug discovery
ind-enabling
phase 1
phase 2
al01211 for fabry disease
al01211 for kidney disease
AL00804 for neuropathic diseases
undisclosed drug discovery program for kidney diseases
In addition to the above, we leverage the rich experience of our internal drug discovery team to discover and develop new drug assets for kidney diseases.